Pharmaceutical News

RSS

Shire's ADHD treatment data to be presented at the Honolulu psychiatric meeting

Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV(TM) (guanfacine) Extended Release Tablets, Vyvanse®( ) (lisdexamfetamine dimesylate) Capsules CII, and Daytrana®( ) (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.

30 Oct 2009

Studies demonstrate that investigational cancer vaccines show encouraging immune response rates

Results of two phase 1 studies demonstrate that the novel, investigational cancer vaccines MKC1106-MT and MKC1106-PP are well-tolerated and show encouraging immune response rates and objective tumor response in advanced melanoma, prostate cancer and other solid malignancies, setting the stage for phase 2 studies.

30 Oct 2009

USANA’s Active Calcium Chewable supplement improves bone health in young girls

USANA Health Sciences, Inc. announced today that a third-party clinical study led by Dr. David Greene at Australian Catholic University (ACU National) found that use of USANA’s Active Calcium™ Chewable supplement improves bone health in young girls.

30 Oct 2009

Any cuts to the prescription drug program will affect senior citizens, says Network/Alliance

The Older Canadians Network / Alliance of Seniors (Network/Alliance) is warning the Ontario government that any cuts to the prescription drug program would disproportionately affect the province's senior citizens.

30 Oct 2009

The Netherlands Antilles Public Health Inspectorate issues importation approval for TNS' ImmuSANO and GlucoSANO

Total Nutraceutical Solutions, Inc., announced today that it has received approval for importation of ImmuSANO™ and GlucoSANO™ from the Inspectorate of Public Health, Bureau of Pharmaceutical Affairs in Curacao, The Netherlands Antilles.

30 Oct 2009

Highly publicized vaccine products not only boost pharmaceutical companies, but also benefit others

Highly publicized vaccine products not only boost the bottom lines of pharmaceutical companies, but also benefit insurance companies, doctors and retailers with their businesses, according to analysis of the recent flu vaccine season by life science market research publisher Kalorama Information.

30 Oct 2009

Virtual Pharma Rep 360 Managed Care solution released

Virtual Pharma Rep™, a new company built by pharmaceutical industry veterans, today announced the release of Virtual Pharma Rep 360 Managed Care. This module builds on the existing Virtual Pharma Rep virtual sales platform of patent pending technology designed to significantly decrease the marketing, sales and educational expenses in the pharmaceutical sales and education process.

30 Oct 2009

Comparative study of chronic wound treatment completed

The comparative study of chronic wound treatment at the Hospital Civil of Cd. Victoria, Tamaulipas, Mexico, was concluded successfully. Due to the significantly superior therapeutic success the Ministry of Health ordered the control to be abandoned and moved to Hemospray treatment for ethical reasons.

30 Oct 2009

FluGen's CHO-cell-based production system generates egg-free, 2009 H1N1 influenza vaccine virus

FluGen Inc., an emerging leader in the development, production and delivery of influenza vaccines, today announced that its proprietary CHO-cell-based production system has generated novel 2009 H1N1 influenza vaccine virus without the use of eggs during any step of production.

30 Oct 2009

All Canadians need to be immunized against H1N1: CPHA

The Canadian Public Health Association (CPHA) announced today that it is encouraging Canadians to get the H1N1 vaccination. To help people make an informed choice, it is launching a new online portal of information.

30 Oct 2009

Researchers use BEZ235 drug to eliminate NSCL cancer

Researchers at UT Southwestern Medical Center have eliminated non-small cell lung (NSCL) cancer in mice by using an investigative drug called BEZ235 in combination with low-dose radiation.

30 Oct 2009

Anabolic steroids may cause severe kidney dysfunction

Athletes who use anabolic steroids may gain muscle mass and strength, but they can also destroy their kidney function, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA.

30 Oct 2009

Dynavax Technologies announces first clinical data for HEPLISAV investigational hepatitis B vaccine

Dynavax Technologies Corporation today announced the first clinical data for HEPLISAVTM investigational hepatitis B vaccine in chronic kidney disease patients.

30 Oct 2009

New online education course on H1N1 vaccination now available

mdBriefCase Inc., in collaboration with the Public Health Agency of Canada (PHAC), is pleased to provide a new online education course on H1N1 vaccination for health professionals.

30 Oct 2009

Researchers show Simvastatin prevents Parkinson's disease from progressing further

Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers at Rush University Medical Center conducted a study examining the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease.

30 Oct 2009

Risk of serious flu-related sickness far outpaces risk of injectable vaccine in pregnant women

Pregnant women who catch the flu are at serious risk for flu-related complications, including death, and that risk far outweighs the risk of possible side effects from injectable vaccines containing killed virus, according to an extensive review of published research and data from previous flu seasons.

30 Oct 2009

Pharmaceutical companies accept Ecuador's decision to break drug patents

Foreign pharmaceutical companies on Wednesday accepted the decision of Ecuador's President Rafael Correa to enable the country "to bypass patents on 2,000 drugs in order to produce them locally or buy cheaper versions elsewhere," Agence France-Presse reports.

30 Oct 2009

U.S. won't donate H1N1 vaccine to developing countries until 'at-risk' Americans receive vaccine

The U.S. will hold off on donating H1N1 (swine flu) vaccine stockpiles to developing countries until "at-risk Americans" receive the vaccine, HHS Secretary Kathleen Sebelius said Wednesday, Agence France-Presse reports

30 Oct 2009

Cumberland Pharmaceuticals and Phebra team up to commercialize Caldolor injection

Cumberland Pharmaceuticals Inc. and Phebra Pty Ltd., an Australian-based specialty pharmaceutical company, today announced they have entered into an exclusive partnership for the commercialization of Caldolor® (ibuprofen) Injection in Australia and New Zealand.

30 Oct 2009

Obama administration hits reset button in wake of flu vaccine shortage

Obama administration officials are working to control the H1N1 flu message after shortages have forced many to wait for the swine flu vaccine.

29 Oct 2009

Pharmaceutical News

Shire's ADHD treatment data to be presented at the Honolulu psychiatric meeting

Studies demonstrate that investigational cancer vaccines show encouraging immune response rates

USANA’s Active Calcium Chewable supplement improves bone health in young girls

Any cuts to the prescription drug program will affect senior citizens, says Network/Alliance

The Netherlands Antilles Public Health Inspectorate issues importation approval for TNS' ImmuSANO and GlucoSANO

Highly publicized vaccine products not only boost pharmaceutical companies, but also benefit others

Virtual Pharma Rep 360 Managed Care solution released

Comparative study of chronic wound treatment completed

FluGen's CHO-cell-based production system generates egg-free, 2009 H1N1 influenza vaccine virus

All Canadians need to be immunized against H1N1: CPHA

Researchers use BEZ235 drug to eliminate NSCL cancer

Anabolic steroids may cause severe kidney dysfunction

Dynavax Technologies announces first clinical data for HEPLISAV investigational hepatitis B vaccine

New online education course on H1N1 vaccination now available

Researchers show Simvastatin prevents Parkinson's disease from progressing further

Risk of serious flu-related sickness far outpaces risk of injectable vaccine in pregnant women

Pharmaceutical companies accept Ecuador's decision to break drug patents

U.S. won't donate H1N1 vaccine to developing countries until 'at-risk' Americans receive vaccine

Cumberland Pharmaceuticals and Phebra team up to commercialize Caldolor injection

Obama administration hits reset button in wake of flu vaccine shortage

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News